Madrigal Pharmaceuticals, Inc. (MDGL)
NASDAQ: MDGL · Real-Time Price · USD
276.19
+2.09 (0.76%)
At close: Jun 6, 2025, 4:00 PM
278.83
+2.64 (0.96%)
After-hours: Jun 6, 2025, 7:14 PM EDT

Madrigal Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
6,1786,7304,5685,1791,4491,719
Upgrade
Market Cap Growth
32.65%47.33%-11.79%257.45%-15.74%22.31%
Upgrade
Enterprise Value
5,4545,8514,4525,0751,1511,384
Upgrade
Last Close Price
278.23308.57231.38290.2584.74111.17
Upgrade
PS Ratio
19.1137.36----
Upgrade
PB Ratio
8.698.9211.2726.247.397.17
Upgrade
P/TBV Ratio
8.758.9811.2726.247.397.17
Upgrade
EV/Sales Ratio
17.1932.48----
Upgrade
Debt / Equity Ratio
0.170.160.290.250.000.00
Upgrade
Asset Turnover
0.310.21----
Upgrade
Quick Ratio
5.415.795.353.103.526.10
Upgrade
Current Ratio
5.916.105.383.123.546.13
Upgrade
Return on Equity (ROE)
-50.16%-80.35%-123.98%-150.12%-110.92%-61.61%
Upgrade
Return on Assets (ROA)
-25.56%-36.98%-47.41%-57.71%-54.09%-35.44%
Upgrade
Return on Capital (ROIC)
-29.54%-44.56%-61.78%-82.62%-69.25%-39.26%
Upgrade
Earnings Yield
-6.34%-6.92%-8.18%-5.70%-16.69%-11.76%
Upgrade
FCF Yield
-6.42%-6.79%-7.13%-4.35%-12.71%-9.18%
Upgrade
Buyback Yield / Dilution
-13.87%-13.83%-9.05%-3.64%-7.05%-0.34%
Upgrade
Updated May 1, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q